B.D. v. Indiana University Health Bloomington Hospital

121 N.E.3d 1044
CourtIndiana Court of Appeals
DecidedMarch 26, 2019
DocketCourt of Appeals Case 18A-MH-2672
StatusPublished
Cited by6 cases

This text of 121 N.E.3d 1044 (B.D. v. Indiana University Health Bloomington Hospital) is published on Counsel Stack Legal Research, covering Indiana Court of Appeals primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
B.D. v. Indiana University Health Bloomington Hospital, 121 N.E.3d 1044 (Ind. Ct. App. 2019).

Opinion

Riley, Judge.

STATEMENT OF THE CASE

[1] Appellant-Respondent, B.D., appeals the trial court's Order temporarily committing her to the care of Appellee-Petitioner, Indiana University Health, Bloomington Hospital (IU Health), for a period not to exceed ninety days.

[2] We affirm.

ISSUES

[3] B.D. presents us with two issues on appeal, which we restate as:

(1) Whether the trial court's determination that B.D. was dangerous to herself was supported by clear and convincing evidence; and
(2) Whether the trial court's forced-medication order was supported by clear and convincing evidence.

FACTS AND PROCEDURAL HISTORY

[4] In the fall of 2018, B.D. was fifty-one years old. B.D. had attempted to commit suicide in the past by overdosing on medication. Early in September 2018, B.D. was treated at Methodist Hospital 1 for manic behavior and substance abuse. B.D. was given injections of the mood stabilizer, Abilify Maintena (Abilify ). B.D. responded well to the Abilify. B.D. was released from Methodist Hospital with a prescription for oral Abilify, but at some point thereafter she stopped taking her medication.

[5] On October 8, 2018, B.D. called a mental-health hotline expressing suicidal ideation and claiming to have overdosed on medication. The authorities were alerted, and officers came to B.D.'s home to check on her well-being but then left. The following day, B.D. contacted the hotline again expressing suicidal ideation. Officers came to B.D.'s home and escorted her to IU Health in Bloomington, where she was held for treatment after the trial court authorized an emergency detention. When B.D. first presented for crisis-care at IU Health, she was experiencing suicidal ideation. B.D. was agitated and unwilling to cooperate with an examination. B.D. banged her head against a gurney and kicked a hole in the wall of the crisis care unit. On October 10, 2018, Dr. Gregory *1047 Sidell (Dr. Sidell) was initially unable to assess B.D. because she was screaming and refusing to talk. When Dr. Sidell was able to assess B.D., she reported having a plan to harm herself with a "[m]edication overdose." (Transcript p. 10). Dr. Sidell diagnosed B.D. with Bipolar Type 1 Disorder with psychotic features.

[6] On October 10, 2018, IU Health filed a petition seeking a temporary involuntary commitment and a forced-medication order for Abilify injections for B.D. On October 12, 2018, the trial court held a hearing on the petition. Dr. Sidell was the sole witness for IU Health. Dr. Sidell testified that on October 11, 2018, B.D. had denied having continuing thoughts of suicide but that he had been informed by a member of Positive Link, a service provider to B.D. who she would contact for emotional support, that B.D. "would tell me and the rest of the hospital staff what she thought we wanted in order to let her go and that she still did have suicidal ideation." (Tr. p. 7). Based upon his own evaluation of B.D. and the report from Positive Link, Dr. Sidell had concluded that B.D. was a danger to herself. Although Dr. Sidell could not make an exact prediction, it was his opinion that there was "definitely a threat" that B.D. would attempt suicide. (Tr. p. 11).

[7] Concerning B.D.'s treatment plan, Dr. Sidell opined that a temporary commitment and Abilify injections were the best treatment options for B.D. Dr. Sidell recommended Abilify to stabilize B.D.'s mood so that she would not experience extreme depression or manic episodes. According to Dr. Sidell, the anger and agitation that B.D. displayed when she first arrived for treatment were hallmark characteristics of a depressive phase of her Bipolar Disorder and that her anger could increase the likelihood of "impulsive suicide action." (Tr. p. 13). Dr. Sidell confirmed that he had considered lesser-restrictive alternative treatment options, including the alternate medication, Invega Sustenna (Invega ). However, Dr. Sidell had rejected Invega as a treatment option because it did not treat depression. B.D. had also requested Adderall, but Dr. Sidell considered that medication to be a poor choice for B.D., given her Bipolar Disorder diagnosis, her history of substance abuse, and its likely tendency to counteract the effects of Abilify. B.D. did not wish to take Abilify because she reported that in the past she had gained twenty pounds and experienced muscle stiffness as side effects of the medication. However, Dr. Sidell was unable to substantiate that weight gain from B.D.'s medical records, and he felt that B.D. could address any weight gain with other medications. It was Dr. Sidell's opinion that the benefits of Abilify injections outweighed its side effects and that it would treat B.D.'s Bipolar Disorder and not just control her symptoms. Dr. Sidell foresaw discharging B.D. with a prescription for oral Abilify and felt that her prognosis was good if she continued to take her medication.

[8] After the close of evidence, the trial court found that B.D. was a danger to herself and issued its Order for a temporary commitment of B.D. not to exceed ninety days. The trial court's Order included a grant of authority to IU Health to treat B.D. with Abilify unless she did not specifically benefit from the medication. On October 19, 2018, B.D. filed a motion to reconsider, which the trial court denied on November 5, 2018.

[9] B.D. now appeals. Additional facts will be provided as necessary.

DISCUSSION AND DECISION

I. Preliminary Matters

[10] On October 12, 2018, B.D. was temporarily committed to the care of IU

*1048 Health for a period not to exceed ninety days, and so the period of temporary commitment has expired. Because the span of a temporary commitment is so short, an appeal is almost always moot by the time briefing is complete. As a general rule, we dismiss controversies that are moot. M.Z. v. Clarian Health Partners , 829 N.E.2d 634 , 637 (Ind. Ct. App. 2005), trans. denied . However, an involuntary commitment is of great public interest and involves issues which are likely to recur, so we generally choose to address the merits of such appeals, despite the mootness of the case. See , e.g. , Matter of Civil Commitment of A.M. , 116 N.E.3d 496 , 502 n.7 (Ind. Ct. App. 2018) (addressing the merits of A.M.'s challenge to her temporary involuntary commitment even though she had likely been discharged from treatment).

[11] As another preliminary matter, we note that on February 21, 2019, B.D.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Cite This Page — Counsel Stack

Bluebook (online)
121 N.E.3d 1044, Counsel Stack Legal Research, https://law.counselstack.com/opinion/bd-v-indiana-university-health-bloomington-hospital-indctapp-2019.